Omlonti 0.002% (0.02 mg/mL) ophthalmic solution Images
Generic Name: omidenepag isopropyl
This medication has been identified as Omlonti 0.002% (0.02 mg/mL) ophthalmic solution. It is supplied by Santen Inc.
Omlonti is used in the treatment of Glaucoma, Open Angle; Glaucoma/Intraocular Hypertension and belongs to the drug class ophthalmic glaucoma agents. Omlonti 0.002% (0.02 mg/mL) ophthalmic solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Omlonti
- Generic Name
- omidenepag isopropyl
- Strength
- 0.002% (0.02 mg/mL) ophthalmic solution
- Availability
- Prescription only
- Drug Class
- Ophthalmic glaucoma agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Santen Inc.
- National Drug Code (NDC)
- 65086-0002
See also:
Lumigan
Lumigan is used to treat open angle glaucoma. Learn about side effects, interactions and indications.
Xalatan
Xalatan (latanoprost) is used to treat certain types of glaucoma. Includes Xalatan side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Cosopt
Cosopt reduces the amount of fluid in the eye and is used to treat glaucoma. Learn about side ...
Combigan
Combigan (brimonidine and timolol) is used to treat glaucoma or ocular hypertension. Includes ...
Alphagan P
Alphagan P is used to treat glaucoma or ocular hypertension (high pressure inside the eye). Learn ...
Vyzulta
Vyzulta is used for glaucoma, open angle, glaucoma/intraocular hypertension
Rhopressa
Rhopressa is used for glaucoma, open angle, intraocular hypertension
Simbrinza
Simbrinza (brimonidine and brinzolamide) is used to treat open-angle glaucoma or ocular ...
More about Omlonti (omidenepag isopropyl ophthalmic)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic glaucoma agents
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.